1887

Abstract

The rise of multi-drug-resistant bacteria poses a global threat. In 2017, the World Health Organization identified 12 antibiotic-resistant ‘priority pathogens’, including Enterobacteriaceae, highlighting the menace of Gram-negative bacteria. Diarrhoeagenic (DEC)-induced diarrhoea is particularly problematic for travellers and infants. In contrast to other antibiotic alternatives, passive immunotherapy is showing promise by providing immediate and precise protection. However, mammalian-sourced antibodies are costly, hindering large-scale production. Egg-laying chicken-derived IgY antibodies present a cost-effective, high-yield solution, revolutionizing antibody-based therapeutics compared to mammalian IgG.

This study hypothesized that developing anti-DEC-IgY could combat DEC infections effectively.

The primary aim was to develop anti-DEC-IgY and assess its potential in DEC-induced diarrhoeal management.

Chickens were immunized with DEC antigens to induce an immune response. IgY antibodies were extracted from immune eggs and purified using ion-exchange column chromatography. Anti-DEC-IgY’s ability to inhibit DEC growth was evaluated through growth inhibition assays. Anti-DEC-IgY’s capacity to prevent adhesion was assessed using mice intestinal mucosa. experiments measured pathogen colonization reduction and infection severity reduction. values were calculated to confirm statistical significance.

The antibacterial efficacy of anti-DEC-IgY by growth inhibition assay demonstrated that 25 mg ml of IgY could inhibit the DEC growth. The anti-adherence-property was tested using mice intestinal mucosa and found that anti-DEC-IgY could prevent the adhesion. results suggest that 12 mg ml of IgY will reduce the pathogen colonization in intestine and reduce the severity of the infection. The values between the experimental groups confirm the statistical significance of the findings.

The study findings suggest that IgY-based passive immunotherapy could be a potential strategy for managing the risks associated with antibiotic-resistant bacterial infections. Additionally, this study paves the way for the development of IgY-related research and applications in India.

Funding
This study was supported by the:
  • Science and Engineering Research Board (Award ECR/2018/002478)
    • Principle Award Recipient: ThirumalaiDiraviyam
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001801
2024-02-05
2024-02-28
Loading full text...

Full text loading...

References

  1. Khan JR, Hossain MB, Chakraborty PA, Mistry SK. Household drinking water E. coli contamination and its associated risk with childhood diarrhea in Bangladesh. Environ Sci Pollut Res Int 2022; 29:32180–32189 [View Article] [PubMed]
    [Google Scholar]
  2. Diarrhoea, Diarrhoeal diseases, diarrhea, acute watery diarrhoea. n.d https://www.who.int/westernpacific/health-topics/diarrhoea
  3. Zhou S-X, Wang L-P, Liu M-Y, Zhang H-Y, Lu Q-B et al. Characteristics of diarrheagenic Escherichia coli among patients with acute diarrhea in China, 2009‒2018. J Infect 2021; 83:424–432 [View Article] [PubMed]
    [Google Scholar]
  4. Seo H, Garcia C, Ruan X, Duan Q, Sack DA et al. Preclinical characterization of immunogenicity and efficacy against diarrhea from MecVax, a multivalent enterotoxigenic E. coli vaccine dandidate. Infect Immun 2021; 89:e0010621 [View Article] [PubMed]
    [Google Scholar]
  5. Angulo-Zamudio UA, Gutiérrez-Jiménez J, Monroy-Higuera L, Flores-Villaseñor H, Leon-Sicairos N et al. Non-diarrheagenic and diarrheagenic E. coli carrying supplementary virulence genes (SVG) are associated with diarrhea in children from Mexico. Microb Pathog 2021; 157:104994 [View Article] [PubMed]
    [Google Scholar]
  6. Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H et al. Alternatives to antibiotics-a pipeline portfolio review. Lancet Infect Dis 2016; 16:239–251 [View Article] [PubMed]
    [Google Scholar]
  7. Karthikeyan M, Indhuprakash ST, Gopal G, Ambi SV, Krishnan UM et al. Passive immunotherapy using chicken egg yolk antibody (IgY) against diarrheagenic E. coli: a systematic review and meta-analysis. Int Immunopharmacol 2022; 102:108381 [View Article] [PubMed]
    [Google Scholar]
  8. Sezonov G, Joseleau-Petit D, D’Ari R. Escherichia coli physiology in Luria-Bertani broth. J Bacteriol 2007; 189:8746–8749 [View Article] [PubMed]
    [Google Scholar]
  9. Takahashi K, Hanamura Y, Tokunoh N, Kassai K, Matsunishi M et al. Protective effects of oral immunization with formalin-inactivated whole-cell Citrobacter rodentium on Citrobacter rodentium infection in mice. J Microbiol Methods 2019; 159:62–68 [View Article] [PubMed]
    [Google Scholar]
  10. Benam SR, Tanomand A, Jafari B. Immunogenic properties of sonicated multivalent antigen of Pseudomonas aeruginosa. CJMB 2018; 5:eISSN
    [Google Scholar]
  11. Polson A, von Wechmar MB, van Regenmortel MH. Isolation of viral IgY antibodies from yolks of immunized hens. Immunol Commun 1980; 9:475–493 [View Article] [PubMed]
    [Google Scholar]
  12. Rahimi S, Moghadam S Z, Zahraei Sa T, A. Karimi M, L. Grimes J. Prevention of Salmonella infection in poultry by specific egg-derived antibody. Int J Poult Sci 2007; 6:230–235 [View Article]
    [Google Scholar]
  13. Pereira EPV, van Tilburg MF, Florean E, Guedes MIF. Egg yolk antibodies (IgY) and their applications in human and veterinary health: a review. Int Immunopharmacol 2019; 73:293–303 [View Article] [PubMed]
    [Google Scholar]
  14. Kumaran T, Beulashiny D, Sujithra S, Uma G, Michael Babu M et al. The production and influence of anti-Vibrio parahaemolytics IgY against experimental infection of V. parahaemolyticus in cultured Fenneropenaeus indicus. Fish Shellfish Immunol 2022; 128:246–259 [View Article] [PubMed]
    [Google Scholar]
  15. Sunwoo HH, Lee EN, Menninen K, Suresh MR, Sim JS. Growth inhibitory effect of chicken egg yolk antibody (IgY) on Escherichia coli O157:H7. J Food Sci 2002; 67:1486–1494 [View Article]
    [Google Scholar]
  16. Sunwoo HH, Lee EN, Gujral N, Suresh MR. Growth inhibition of Escherichia coli 987P by neutralizing IgY antibodies. TOIJ 2010; 3:1–8 [View Article]
    [Google Scholar]
  17. Wu CJ, Wang H, Chan YL, Li TL. Passive immune-protection of small abalone against Vibrio alginolyticus infection by anti-Vibrio IgY-encapsulated feed. Fish Shellfish Immunol 2011; 30:1042–1048 [View Article] [PubMed]
    [Google Scholar]
  18. Li X-Y, Jin L-J, McAllister TA, Stanford K, Xu J-Y et al. Chitosan-alginate microcapsules for oral delivery of egg yolk immunoglobulin (IgY). J Agric Food Chem 2007; 55:2911–2917 [View Article] [PubMed]
    [Google Scholar]
  19. Jin LZ, Baidoo SK, Marquardt RR, Frohlich AA. In vitro inhibition of adhesion of enterotoxigenic Escherichia coli K88 to piglet intestinal mucus by egg-yolk antibodies. FEMS Immunol Med Microbiol 1998; 21:313–321 [View Article] [PubMed]
    [Google Scholar]
  20. Ahmadi TS, Mousavi Gargari SL, Talei D. Anti-flagellin IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound murine models in a non-type-specific mode. Mol Immunol 2021; 136:118–127 [View Article] [PubMed]
    [Google Scholar]
  21. Lee K-A, Chang S-K, Lee Y-J, Lee J-H, Koo N-S. Acid stability of anti-Helicobacter pyroli IgY in aqueous polyol solution. BMB Reports 2002; 35:488–493 [View Article] [PubMed]
    [Google Scholar]
  22. Wang Z, Li J, Li J, Li Y, Wang L et al. Protective effect of chicken egg yolk immunoglobulins (IgY) against enterotoxigenic Escherichia coli K88 adhesion in weaned piglets. BMC Vet Res 2019; 15:1–12 [View Article] [PubMed]
    [Google Scholar]
  23. Gujral N, Yoo H, Bamdad F, Lee KY, Suh J-W et al. A combination of egg yolk IgY and phosvitin inhibits the growth of enterotoxigenic Escherichia coli K88 and K99. CPB 2017; 18:400–409 [View Article]
    [Google Scholar]
  24. Amaral JA, De Franco MT, Zapata-Quintanilla L, Carbonare SB. In vitro reactivity and growth inhibition of EPEC serotype O111 and STEC serotypes O111 and O157 by homologous and heterologous chicken egg yolk antibody. Vet Res Commun 2008; 32:281–290 [View Article] [PubMed]
    [Google Scholar]
  25. Abdulkadieva MM, Sysolyatina EV, Vasilieva EV, Gusarov AI, Domnin PA et al. Strain specific motility patterns and surface adhesion of virulent and probiotic Escherichia coli. Sci Rep 2022; 12:614 [View Article] [PubMed]
    [Google Scholar]
  26. Bustos CP, Leiva CL, Gambarotta M, Guida N, Chacana PA. In vitro inhibitory activity of IgY antibodies against Salmonella ser. newport isolated from horses. J Equine Vet Sci 2021; 103:103657 [View Article] [PubMed]
    [Google Scholar]
  27. Vanmarsenille C, Elseviers J, Yvanoff C, Hassanzadeh-Ghassabeh G, Garcia Rodriguez G et al. In planta expression of nanobody-based designer chicken antibodies targeting Campylobacter. PLoS One 2018; 13:e0204222 [View Article] [PubMed]
    [Google Scholar]
  28. Alustiza F, Bellingeri R, Picco N, Motta C, Grosso MC et al. IgY against enterotoxigenic Escherichia coli administered by hydrogel-carbon nanotubes composites to prevent neonatal diarrhoea in experimentally challenged piglets. Vaccine 2016; 34:3291–3297 [View Article] [PubMed]
    [Google Scholar]
  29. Han S, Wen Y, Yang F, He P. Chicken egg yolk antibody (IgY) protects mice against Eenterotoxigenic Escherichia coli infection through improving intestinal health and immune response. Front Cell Infect Microbiol 2021; 11:662710 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001801
Loading
/content/journal/jmm/10.1099/jmm.0.001801
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error